Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.

Autor: Dorvil N; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Rivera VR; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Riviere C; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Berman R; The Analysis Group, Boston, Massachusetts, United States of America., Severe P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Bang H; University of California, Davis School of Medicine, Davis, California, United States of America., Lavoile K; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Devieux JG; Florida International University, Miami, Florida, United States of America., Faustin M; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Saintyl G; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Mendicuti MD; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Pierre S; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Apollon A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Dumond E; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Forestal GPL; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Rouzier V; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America., Marcelin A; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., McNairy ML; Weill Cornell Medicine, New York, New York, United States of America., Walsh KF; Weill Cornell Medicine, New York, New York, United States of America., Dupnik K; Weill Cornell Medicine, New York, New York, United States of America., Reif LK; Weill Cornell Medicine, New York, New York, United States of America., Byrne AL; St. Vincent's Hospital, Darlinghurst, New South Wales, Australia., Bousleiman S; The Analysis Group, Boston, Massachusetts, United States of America., Orvis E; The Analysis Group, Boston, Massachusetts, United States of America., Joseph P; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Cremieux PY; The Analysis Group, Boston, Massachusetts, United States of America., Pape JW; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.; Weill Cornell Medicine, New York, New York, United States of America., Koenig SP; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

Publikováno v: PLoS medicine [PLoS Med] 2023 Jun 09; Vol. 20 (6), pp. e1004246. Date of Electronic Publication: 2023 Jun 09 (Print Publication: 2023).